A Brief Intervention by Nurses to Reduce the Prescribing of Occluded Peripheral Venous Catheters in the Emergency Department

NCT07584590 | Not Yet Recruiting

• 1 other identifier: 2023/0302/HP
• Study Type: interventional
• Target: 1,680
• Locations: 1 country
• Sites: 16

Brief Summary

Peripheral venous catheters are frequently inserted in hospitals, with approximately 25 million placed annually in France (HAS data, 2005). The occluded peripheral venous catheter with extension tubing has become the standard in some emergency departments, offering advantages such as patient mobility, the ability to perform repeated blood draws, and the administration of intravenous medications. A 2018 meta-analysis revealed that one in three devices was unnecessary. The placement of a occluded peripheral venous is associated with a more painful insertion, higher cost, and an increased risk of infection and thromboembolism, and blood samples obtained via the occluded peripheral venous catheter are more often hemolyzed than those obtained by direct venipuncture. Communication between physicians and nurses is essential to ensure optimal patient care. A brief intervention by the nurse when a physician prescribes a occluded peripheral venous catheter can help clarify the appropriateness of this prescription, which could lead to reduced pain for the patient, time savings for healthcare providers, and material cost savings for the hospital.

Conditions

an Initial Order for a Blood Draw and Placement of an IV Line in the Emergency Department

Outcome Measures

Primary Outcomes (1)

• the proportion of obturator catheters placed improperly

  Questions for the prescriber

  day 1

Secondary Outcomes (5)

• Correlation between the physician's final decision and nurse activity

  day 1

• Use of the numerical pain scale during obturator catheter placement

  at the end of procedure (assessed up to 20 minutes)

• Micro-costing analysis

  at the end of procedure (assessed up to 20 minutes)

• Types of intravenous medications administered

  day 1

• Number of orders for obturator catheters

  day 1

Study Arms (1)

Questions for the prescriber

EXPERIMENTAL

Once the nurse has received the doctor's order for a blood draw with a KTO, she will ask the prescribing physician: Is the KTO being prescribed for: the administration of medication? The injection of a contrast agent? A second blood draw? For each question, there are three possible answers: Yes? No? Maybe?

Other: question for the prescriber

Interventions

question for the prescriber OTHER

Once the nurse has received the doctor's order for a blood draw with a KTO, she will ask the prescribing physician: Is the KTO being prescribed for: the administration of medication? The injection of a contrast agent? A second blood draw? For each question, there are three possible answers: Yes? No? Maybe?

Questions for the prescriber

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients assigned a triage score of 3A, 3B, or 4 according to the French triage scale, or 3 or 4 according to the CIMU triage scale, by the triage nurse
• Patients with a blood draw order involving the placement of an occluded catheter
• Age 18 years or older
• Patients who have read and understood the information sheet
• Patients who have given their verbal consent to participate in the study
• Patients enrolled in a social security program

You may not qualify if:

• Patients admitted to the emergency department with a pre-existing intravenous line
• Patients treated by the Mobile Emergency and Resuscitation Unit outside the hospital
• Patients with a blocked catheter who did not undergo an initial blood draw
• Patient with known neurocognitive disorders incompatible with informed consent
• Pregnant or breastfeeding woman
• Patient under legal guardianship (guardianship or conservatorship) or patient deprived of liberty
• Patient refusing to participate in the study
• Patient participating in another interventional research study

Sponsors & Collaborators

• University Hospital, Rouen: lead

Study Sites (16)

CHU Amiens

Amiens, 80 000, France

Location

CHU Angers

Angers, 49 100, France

Location

Chu Clermont Ferrand

Clermont-Ferrand, 63 000, France

Location

APHP Henri Mondor

Créteil, 94 010, France

Location

Ch Dieppe

Dieppe, 76 202, France

Location

APHP CH Simone Veil

Eaubonne, 95 600, France

Location

HCL Lyon Sud

Lyon, 69 495, France

Location

HIA Laveran Marseille

Marseille, 13013, France

Location

CHRU Nancy

Nancy, 54 000, France

Location

CHU Nantes

Nantes, 44 093, France

Location

APHP Lariboisière

Paris, 75 010, France

Location

AP HP Pitié Salpétrière

Paris, 75 013, France

Location

APHP Bichat

Paris, 75 018, France

Location

APHP St Antoine

Paris, 76 012, France

Location

CHU de ROUEN

Rouen, 76 031, France

Location

Chu Toulouse

Toulouse, 31 300, France

Location

Study Officials

• Déborah LEBEDIEFF, MS

  University Hospital, Rouen

  STUDY CHAIR

Central Study Contacts

Jessica BORTZMEYER, nurse

CONTACT

02.32.88.89.90; jessica.bortzmeyer@chu-rouen.fr

ROUSSEL Mélanie, MD

CONTACT

melanie.roussel@chu-rouen.fr

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SEQUENTIAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 27, 2026
• First Posted: May 13, 2026
• Study Start (Estimated): June 1, 2026
• Primary Completion (Estimated): January 1, 2027
• Study Completion (Estimated): January 1, 2027
• Last Updated: May 13, 2026

Record last verified: 2026-05

Data Sharing

• IPD Sharing: Will not share

Locations

FR (16)